Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GEHC vs GSK✓SelectedUSD · GSKGEHC vs GSK performance historyLatest closeAs of-2.12%11/19
Stock and ETF performance explorer

GEHC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+37.4%
GSK return
+54.9%
Excess return
-17.6%
Maximum drawdown
-37.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.6%-0.6%-1.6%
7D+0.1%-4.7%+4.8%+1.7%
30D+16.7%-4.7%+21.4%+18.4%
3M+9.8%-8.8%+18.6%+12.9%
6M+33.1%-4.6%+37.8%+34.8%
YTD0.0%+1.0%-1.0%+0.6%
1Y+13.5%+6.9%+6.6%+12.8%
3Y+12.8%+52.5%-39.8%+3.3%
All+37.4%+54.9%-17.6%+26.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling